Correlation Between Microbot Medical and NeoGenomics

Can any of the company-specific risk be diversified away by investing in both Microbot Medical and NeoGenomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microbot Medical and NeoGenomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Microbot Medical and NeoGenomics, you can compare the effects of market volatilities on Microbot Medical and NeoGenomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microbot Medical with a short position of NeoGenomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microbot Medical and NeoGenomics.

Diversification Opportunities for Microbot Medical and NeoGenomics

-0.38

Correlation Coefficient

Microbot Medical  NeoGenomics

Very good diversification

The 3 months correlation between Microbot and NeoGenomics is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Microbot Medical and NeoGenomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeoGenomics and Microbot Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microbot Medical are associated (or correlated) with NeoGenomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeoGenomics has no effect on the direction of Microbot Medical i.e., Microbot Medical and NeoGenomics go up and down completely randomly.

Pair Corralation between Microbot Medical and NeoGenomics

Given the investment horizon of 90 days Microbot Medical is expected to generate 1.07 times more return on investment than NeoGenomics. However, Microbot Medical is 1.07 times more volatile than NeoGenomics. It trades about 0.09 of its potential returns per unit of risk. NeoGenomics is currently generating about -0.04 per unit of risk. If you would invest  257.00  in Microbot Medical on May 22, 2025 and sell it today you would earn a total of  52.00  from holding Microbot Medical or generate 20.23% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Microbot Medical  vs.  NeoGenomics

Microbot Medical

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Microbot Medical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Microbot Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

NeoGenomics

Risk-Adjusted Performance

Weakest

Over the last 90 days NeoGenomics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Microbot Medical and NeoGenomics

The main advantage of trading using opposite Microbot Medical and NeoGenomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microbot Medical position performs unexpectedly, NeoGenomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeoGenomics will offset losses from the drop in NeoGenomics' long position.

The idea behind Microbot Medical and NeoGenomics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.